First Command Advisory Services’s Takeda Pharmaceutical TAK Stock Holding History

First Command Advisory Services's TAK Position: Q2 2026 in Review

First Command Advisory Services increased its Takeda Pharmaceutical (TAK) stake by 262% in Q2 2026, buying an estimated $239K and bringing the position to 19,934 shares worth $320K. The position accounts for ﹤0.01% of the portfolio, ranked #164.

First Command Advisory Services first reported a position in TAK in Q1 2026 and has held it in 2 quarters since. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

• First Command Advisory Services held 19,934 shares of Takeda Pharmaceutical worth $320K as of Q2 2026.
• First Command Advisory Services bought 14,429 Takeda Pharmaceutical shares in Q2 2026, an estimated $239K.
• Takeda Pharmaceutical made up ﹤0.01% of First Command Advisory Services's portfolio in Q2 2026, its #164 holding.
• First Command Advisory Services first reported a position in Takeda Pharmaceutical in Q1 2026 and has held it in 2 quarters since.
• 376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on First Command Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.